| |
| |
|
|
2009
R million
(Audited) |
|
|
2008
R million
(Audited) |
| Share capital and premium |
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
106,9 |
|
|
90,8 |
| Issue of shares |
|
|
9,1 |
|
|
16,1 |
| Balance at the end of the year |
|
|
116,0 |
|
|
106,9 |
| Share-based payment reserve |
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
664,3 |
|
|
649,9 |
| Share-based payment expense and deferred tax there on |
|
|
15,3 |
|
|
14,4 |
| Balance at the end of the year |
|
|
679,6 |
|
|
664,3 |
| Fair value adjustment reserve* |
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
621,1 |
|
|
— |
| Arising on fair valuation of financial instruments |
|
|
(321,9) |
|
|
660,3 |
| Deferred taxation on fair value loss/(gain) |
|
|
39,2 |
|
|
(39,2) |
| Balance at the end of the year |
|
|
338,4 |
|
|
621,1 |
| Equity transaction with BEE partner |
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
(35,3) |
|
|
— |
Purchase of a portion of BEE partner's interest in a subsidiary not previously recognised
as a minority |
|
|
— |
|
|
(35,3) |
| Balance at the end of the year |
|
|
(35,3) |
|
|
(35,3) |
| Treasury shares |
|
|
(276,1) |
|
|
(276,1) |
| Non-distributable reserves |
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
4,1 |
|
|
7,3 |
| Foreign currency translation reserve |
|
|
(0,9) |
|
|
0,7 |
Reunert's share of previously equity-accounted associate's actuarially valued surplus
of medical aid provision** |
|
|
— |
|
|
(3,9) |
| Transfer from retained earnings |
|
|
8,7 |
|
|
— |
| Balance at the end of the year |
|
|
11,9 |
|
|
4,1 |
| Retained earnings |
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
2 590,4 |
|
|
1 997,1 |
| Profit for the year |
|
|
1 164,5 |
|
|
1 156,6 |
Reunert's share of previously equity-accounted associate's actuarially valued surplus
of medical aid provision transferred from non-distributable reserves** |
|
|
— |
|
|
3,9 |
| Transferred to non-distributable reserves |
|
|
(8,7) |
|
|
— |
| Cash dividends declared and paid |
|
|
(546,3) |
|
|
(567,2) |
| Balance at the end of the year |
|
|
3 199,9 |
|
|
2 590,4 |
| Equity attributable to equity holders of Reunert Limited |
|
|
4 034,4 |
|
|
3 675,4 |
| Minority interest |
|
|
|
|
|
|
| Balance at the beginning of the year |
|
|
20,7 |
|
|
14,4 |
| Profit for the year |
|
|
9,0 |
|
|
7,1 |
| Dividends declared and paid |
|
|
(4,0) |
|
|
(1,8) |
| Minority interest introduced |
|
|
1,0 |
|
|
1,0 |
| Balance at the end of the year |
|
|
26,7 |
|
|
20,7 |
| Total equity at the end of the year |
|
|
4 061,1 |
|
|
3 696,1 |
**This reserve relates to fair value adjustments on financial assets classified as "available-for-sale" financial assets in terms of IAS 39.
**Since Reunert's investment in NSN is no longer equity-accounted this reserve has been transferred to retained earnings. |
| |
|
|
